Search

Dennis J Kopecko

from Richmond, VA
Age ~77
Get Report
Also known as:
Dennis Jon Kopecko, Dennis A Kopecko, Dennis J Kopek, Dennis O
Related to:
Jennifer K Kopecko, 43Patricia G Kopecko, 78
Connected to:
Brian A Kopecky, 43Donald L Kopecky, 67Emma G Kopecky, 38Frank J Kopecky, 53James R Kopecky, 74John S Kopecky, 64Jordan N Kopecky, 32Kathy Kopecky, 76Keet L Kopecky, 69Mardi Kopecky, 72

Dennis Kopecko Phones & Addresses

  • Richmond, VA
  • Rockville, MD
  • Anthem, AZ
  • Scottsdale, AZ
  • 16325 Whitehaven Rd, Silver Spring, MD 20906 (301) 570-7967
  • Bethesda, MD

Work

Company: Protein potential Position: Vice president, bacterial vaccines

Industries

Biotechnology

Resumes

Resumes

Dennis Kopecko Photo 1

Vice President, Bacterial Vaccines

View page
Location:
Rockville, MD
Industry:
Biotechnology
Work:
Protein Potential
Vice President, Bacterial Vaccines

Publications

Us Patents

Vaccine For Protection Against Disease

View page
US Patent:
7541043, Jun 2, 2009
Filed:
Jan 15, 2003
Appl. No.:
10/346706
Inventors:
Dennis J. Kopecko - Silver Spring MD, US
John O. Cisar - Gaithersburg MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 39/112
US Classification:
4242581, 424 932, 424 9348
Abstract:
Compositions and methods for protecting a susceptable host against an infection of are disclosed. Such compositions and methods are useful for protecting the host against bacillary dysentery and shigellosis.

Dna Promoters And Anthrax Vaccines

View page
US Patent:
7758855, Jul 20, 2010
Filed:
Mar 17, 2006
Appl. No.:
11/378003
Inventors:
Dennis J. Kopecko - Silver Spring MD, US
Manuel Osorio - Bethesda MD, US
Siba Bhattacharyya - Bethesda MD, US
Chandrakant P. Giri - Rockville MD, US
Milan Blake - Fulton MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 48/00
C12N 15/74
C12N 1/20
US Classification:
424 932, 435471, 4352528
Abstract:
The invention is related to intracellularly induced bacterial DNA promoters and vaccines against.

Vaccine For Protection Against Disease

View page
US Patent:
8071084, Dec 6, 2011
Filed:
May 28, 2009
Appl. No.:
12/474223
Inventors:
Dennis J. Kopecko - Silver Spring MD, US
John O. Cisar - Gaithersburg MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 39/112
US Classification:
424 932
Abstract:
Compositions and methods for protecting a susceptible host against an infection of are disclosed. Such compositions and methods are useful for protecting the host against bacillary dysentery and shigellosis.

Live, Oral Vaccine For Protection Against Serotype 1

View page
US Patent:
8071113, Dec 6, 2011
Filed:
May 24, 2005
Appl. No.:
11/597301
Inventors:
Dennis J. Kopecko - Silver Spring MD, US
DeQi Xu - Columbia MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 39/112
A61K 39/02
C07H 21/04
US Classification:
4242581, 424 931, 424 932, 4241841, 4242001, 4242031, 4242341, 536 231, 536 237
Abstract:
The invention relates to Ty21a comprising core-linked serotype 1 O-specific polysaccharide (O-Ps) and DNA encoding O antigen biosynthesis, said DNA selected from the group consisting of: a) the DNA sequence set out in any one of SEQ ID NOs: 1 and 2 and species homologs thereof; b) DNA encoding serotype 1 polypeptides encoded by any one of SEQ ID NOs: 1 and 2, and species homologs thereof; and c) DNA encoding a O antigen biosynthesis gene product that hybridizes under moderately stringent conditions to the DNA of (a) or (b); and related sequences, compositions of matter, vaccines, methods of using, and methods of making.

Dna Promoters And Anthrax Vaccines

View page
US Patent:
8247225, Aug 21, 2012
Filed:
Jun 8, 2010
Appl. No.:
12/796410
Inventors:
Dennis J. Kopecko - Silver Spring MD, US
Manuel Osorio - Bethesda MD, US
Siba Bhattacharyya - Bethesda MD, US
Milan Blake - Fulton MD, US
Assignee:
The United States of America, as Represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
C12N 15/74
C12N 15/11
C12N 1/21
US Classification:
4353201, 536 241, 4352523, 435471
Abstract:
The invention is related to intracellularly induced bacterial DNA promoters and vaccines against.

Live, Oral Vaccine For Protection Against Serotype 1

View page
US Patent:
8337831, Dec 25, 2012
Filed:
Oct 31, 2011
Appl. No.:
13/285614
Inventors:
Dennis J Kopecko - Silver Spring MD, US
Deqi Xu - Columbia MD, US
Assignee:
The United States of America, as Represented by the Secrectary, Department of Health and Human Services - Washington DC
International Classification:
A01N 63/00
C07H 21/02
C07H 21/04
US Classification:
424 932, 424 931, 4241841, 4242001, 4242031, 4242341, 536 231, 536 237
Abstract:
The invention relates to Ty21a comprising core-linked serotype 1 O-specific polysaccharide (O-Ps) and DNA encoding O antigen biosynthesis, said DNA selected from the group consisting of: a) the DNA sequence set out in any one of SEQ ID NOs: 1 and 2 and species homologs thereof; b) DNA encoding serotype 1 polypeptides encoded by any one of SEQ ID NOs: 1 and 2, and species homologs thereof; and c) DNA encoding a O antigen biosynthesis gene product that hybridizes under moderately stringent conditions to the DNA of (a) or (b); and related sequences, compositions of matter, vaccines, methods of using, and methods of making.

Vaccine For Protection Against Disease

View page
US Patent:
8337832, Dec 25, 2012
Filed:
Nov 14, 2011
Appl. No.:
13/295811
Inventors:
Dennis J. Kopecko - Silver Spring MD, US
Deqi Xu - Columbia MD, US
John O. Cisar - Gaithersburg MD, US
Assignee:
The United States of America, As Represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61K 39/02
C07H 21/00
US Classification:
424 932, 536 237
Abstract:
Compositions and methods for protecting a susceptible host against an infection of are disclosed. Such compositions and methods are useful for protecting the host against bacillary dysentery and shigellosis.

Attenuated Salmonella As A Delivery System For Sirna-Based Tumor Therapy

View page
US Patent:
20090208534, Aug 20, 2009
Filed:
Jul 24, 2007
Appl. No.:
12/374916
Inventors:
Deqi Xu - Colombia MD, US
Dennis J. Kopecko - Silver Spring MD, US
Jiadi Hu - Columbia MD, US
Ling Zhang - Changchun City, CN
Xuejian Zhao - Changchun City, CN
Lifang Gao - Changchun City, CN
Assignee:
The Government of The United States of America, as represented by the Secretary, Dept.of Health - Rockville MD
International Classification:
A61K 39/112
C12N 1/20
A61P 35/00
US Classification:
4242581, 4352528
Abstract:
The invention relates to an attenuated sp. that is capable of targeting a solid tumor when administered in vivo comprising a short hairpin (sh) RNA construct, and methods of inhibiting the growth or reducing the volume of a solid tumor cancer comprising administering an effective amount of an attenuated sp. to a patient having a solid tumor cancer, wherein said attenuated sp. is a tumor targeting attenuated sp. expressing a short hairpin (sh) RNA which attenuated sp. is capable of inhibiting the growth or reducing the volume of the solid tumor cancer when administered in vivo.
Control profile
Dennis J Kopecko from Richmond, VA, age ~77 Get Report